Pseudotumor cerebri pathophysiology

Headache

Volumn 54, Issue 3, 2014, Pages 445-458

  McGeeney, Brian E ^a   Friedman, Deborah I ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

cerebral venous system; idiopathic intracranial hypertension; pathophysiology; pseudotumor cerebri; retinol

Indexed keywords

ACETAZOLAMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; ARGIPRESSIN; CORTICOSTEROID; NATRIURETIC FACTOR; RETINOL; SEX HORMONE; VASOPRESSIN;

ADIPOSE TISSUE; BRAIN PSEUDOTUMOR; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID PRESSURE; DISEASE ASSOCIATION; HUMAN; INTRACRANIAL PRESSURE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINUS VENOSUS; SLEEP DISORDERED BREATHING; TRANSVERSE SINUS; FEMALE; MALE;

FEMALE; HUMANS; MALE; PSEUDOTUMOR CEREBRI;

EID: 84895872061     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12291     Document Type: Review

References (121)

1. Raoof N, Sharrack B, Pepper IM, Hickman SJ,. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol. 2011; 18: 1266-1268.
2. Wall M,. Idiopathic intracranial hypertension and the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol. 2013; 33: 1-3.
3. Friedman DI, Liu G, Digre KB,. Diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013; 81: 1159-1165.
4. Avery RA, Shah SS, Licht DJ, et al. Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med. 2010; 363: 891-893.
5. Butros SR, Goncalves LF, Thompson D, Agarwal A, Lee HK,. Imaging features of idiopathic intracranial hypertension, including a new finding: Widening of the foramen of ovale. Acta Radiol. 2012; 53: 682-688.
6. Johnston I, Owler B, Pickard J, eds. The Pseudotumor Cerebri Syndrome. Cambridge, UK.: Cambridge University Press; 2007.
7. Passot R,. Meningites et etats meninges aseptiques d'origine otique. In: These de Paris. Paris: G. Steinheil; 1913. no. 247.
8. Hughlings Jackson J,. Discussion on the relationship between optic neuritis and intracranial disease. Trans Ophthalmol Soc UK. 1880; 1: 60-115.
9. Nonne M,. Der pseudotumor cerebri. Neue Deutsche Chirurgie. 1914: 107-152.
10. Quincke H,. Meningitis serosa. Sammi Klin Vortr., Leipzig, No. 67. Inn Med. 1893; 23: 655.
11. Symonds CP,. Otic hydrocephalus. Brain. 1931; 54: 55-71.
12. Davidoff LM, Dyke CG,. Hypertensive meningeal hydrops. Am J Ophthalmol. 1937; 20: 908-927.
13. Dandy WE,. Intracranial pressure without brain tumor: Diagnosis and treatment. Ann Surg. 1937; 106: 492-513.
14. Foley J,. Benign forms of intracranial hypertension. Toxic and otitic hydrocephalus. Brain. 1955; 78: 1-41.
15. Milhorat TH,. Physiology of the cerebrospinal fluid. In:, Milhorat TH, ed. Cerebrospinal Fluid and Brain Edemas. New York: Neuroscience Society of New York; 1987: 39-73.
16. Johanson CE, Donahue JE, Spangenberger A, Stopa EG, Duncan JA, Sharma HS,. Atrial natriuretic peptide: Its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation. Acta Neurochir Suppl. 2006; 96: 451-456.
17. Redzic ZB, Preston JE, Duncan JA, Chodobski A, Szmydynger-Chodobska J,. The choroid plexus-cerebrospinal fluid system: From development to aging. Curr Top Dev Biol. 2005; 71: 1-52.
18. Maren TH,. The kinetics of HCO3- synthesis related to fluid secretion, pH control, and CO2 elimination. Annu Rev Physiol. 1998; 50: 695-717.
19. Tripathi BJ, Tripathi RC,. Vacuolar transcellular channel as a drainage pathway for cerebrospinal fluid. J Physiol. 1974; 239: 195-206.
20. Weller RO, Djuanda E, Yow HY, Carare RO,. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol. 2009; 117: 1-14.
21. Johnson M, Zakharov A, Papaiconomou C, Salmasi G, Armstrong D,. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels of humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res. 2004; 1: 1-13.
22. Edsbagge M, Tisell M, Jacobsson L, Wikkelso C,. Spinal CSF absorption in healthy individuals. Am J Physiol Regul Integr Comp Physiol. 2004; 287: R1450-R1455.
23. Benga O, Huber VJ,. Brain water channel proteins in health and disease. Mol Aspects Med. 2012; 33: 562-578.
24. Tanimura Y, Hiroaki Y, Fujiyoshi Y,. Acetazolamide reversibly inhibits water conduction by aquaporin-4. J Struct Biol. 2009; 166: 16-21.
25. Ameil PA, Madan M, Chigurupati S, Yu A, Chan SL, Pattisapu JV,. Effect of acetazolamide on aquaporin-1 and fluid flow in cultured choroid plexus. Acta Neurochir Suppl. 2012; 113: 59-64.
26. Huber VJ, Tsujita M, Kwee IL, Nakada T,. Inhibition of aquaporin 4 by antiepileptic drugs. Bioorg Med Chem. 2009; 17: 418-424.
27. Kerty E, Heuser K, Indahl UG, et al. Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol. 2013; 91: 88-91.
28. Sklar FH, Reisch J, Elashvili I, Smith T, Long DM,. Effects of pressure on cerebrospinal fluid formation: Non steady-state measurements in dogs. Am J Physiol. 1980; R277-R284.
29. Welch K,. The principles of physiology of the cerebrospinal fluid in relation to hydrocephalus including normal pressure hydrocephalus. Adv Neurol. 1975; 13: 247-332.
30. Sahar A,. The effect of pressure on the production of cerebrospinal fluid by the chorioid plexus. J Neurol Sci. 1972; 26: 49-58.
31. Donaldson JO,. Cerebrospinal fluid hypersecretion in pseudotumor cerebri. Trans Am Neurol Assoc. 1979; 104: 196-198.
32. Johnson IH, Paterson A,. Benign intracranial hypertension. II CSF pressure and circulation. Brain. 1974; 97: 301-312.
33. Mann JD, Johnson RN, Butler AB, Bass NH,. Cerebrospinal fluid circulatory dynamics in pseudotumor cerebri and response to steroid treatment. Neurology. 1979; 29: 550.
34. Gjerris P, Sorensen PS, Vorstrup S, Paulson OB,. Intracranial pressure, conductance to CSF outflow and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri). Ann Neurol. 1985; 17: 158-162.
35. Janny P, Chazal J, Colnet G, Irthum B, George AM,. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol. 1981; 15: 168-174.
36. Alperin N, Ranganathan S, Bagci AM, et al. MRI evidence of impaired CSF homeostasis in obesity-associated idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2013; 34: 29-34.
37. Alperin N, Lam BL, Tain RW, et al. Evidence for altered spinal canal compliance and cerebral venous drainage in untreated idiopathic intracranial hypertension. Acta Neurochir Suppl. 2012; 114: 201-205.
38. Owler BK, Parker G, Halmagyi GM,et al. Cerebral venous outflow obstruction and pseudotumor cerebri syndrome. Adv Tech Stand Neurosurg. 2005; 30: 108-178.
39. King JO, Mitchell PJ, Thomson KR, Tress BM,. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology. 1995; 45: 2224-2228.
40. King JO, Mitchell PJ, Thomson KR, Tress BM,. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology. 2002; 58: 26-30.
41. Higgins JN, Pickard JD,. Letter in reply to King et al. Neurology. 2002; 59: 963-964.
42. Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: The prevalence and morphology of sinovenous stenosis. Neurology. 2003; 60: 1418-1424.
43. Alper F, Kantarci M, Dane S, et al. Importance of anatomical asymmetries of transverse sinuses: An MR venographic study. Cerebrovasc Dis. 2004; 18: 236-239.
44. Roche J, Warner D,. Arachnoid granulations in the transverse and sigmoid sinuses: CT, MR, and MR angiographic appearances of a normal anatomic variation. Am J Neuroradiol. 1996; 17: 677-683.
45. Arjona A, Delgado F, Fernandez-Romero E,. Intracranial hypertension secondary to giant arachnoid granulations. J Neurol Neurosurg Psychiatry. 2003; 74: 418.
46. Bedford THB,. The effect of increased intracranial venous pressure in the pressure of the cerebrospinal fluid. Brain. 1935; 58: 427-447.
47. Bateman GA,. Idiopathic intracranial hypertension: Priapism of the brain? Med Hypotheses. 2004; 63: 549-552.
48. Rohr A, Bindeballe J, Riedel C, et al. The entire dural sinus tree is compressed in patients with idiopathic intracranial hypertension: A longitudinal volumetric magnetic resonance imaging study. Neuroradiology. 2012; 54: 25-33.
49. Ahmed R, Friedman DI, Halmagyi GM,. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol. 2011; 31: 374-380.
50. Dwyer CM, Prelog K, Owler BK,. The role of venous sinus outflow obstruction in pediatric idiopathic intracranial hypertension. J Neurosurg Pediatr. 2013; 11: 144-149.
51. Koerner J, Friedman DI,. Inpatient and emergency service utilization in patients with idiopathic intracranial hypertension. J Neuroophthalmol. In Press.
52. Bono F, Messina D, Giliberto C, et al. Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology. 2006; 67: 419-423.
53. Bono F, Messina D, Giliberto C, et al. Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol. 2008; 255: 807-812.
54. Digre KB, Nakamoto BK, Warner JE, et al. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009; 49: 185-193.
55. Neville L, Egan RA,. Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can J Ophthalmol. 2005; 40: 775-777.
56. Benzer A, Gottardis M, Russegger L, Langmayr J, Balogh D,. Fentanyl increases cerebrospinal fluid pressure in normocapnic volunteers. Eur J Anaesthesiol. 1992; 9: 473-477.
57. Glueck CJ, Aregawi D, Goldberg N, et al. Idiopathic intracranial hypertension, polycystic ovary syndrome, and thrombophilia. J Lab Clin Med. 2005; 145: 72-82.
58. Bowles LK, Cooper JA, Howarth DJ, Miller GJ, MacCallum PK,. Associations of haemostatic variables with body mass index: A community-based study. Blood Coagul Fibrinolysis. 2003; 14: 569-573.
59. Kesler A, Yatziv Y, Shapira I, Berliner S, Assayag EB,. Increased red blood cell aggregation in patients with idiopathic intracranial hypertension. A hitherto unexplored pathophysiological pathway. Thromb Haemost. 2006; 96: 483-487.
60. Weber KT,. Aldersteronism revisited: Perspectives on less well-recognized actions of aldosterone. J Lab Clin Med. 2003; 142: 71-82.
61. Weber KT, Singh KD, Hey JC,. Idiopathic intracranial hypertension with primary hyperaldosteronism. Report of two cases. Am J Med Sci. 2002; 324: 45-50.
62. Conn JW, Knopf RF, Nesbit RM,. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg. 1964; 107: 159-172.
63. Kageyama Y, Suzuki H, Saruta T,. Presence of aldeosterone-like immunoreactivity in cerebrospinal fluid in normotensive subjects. Acta Endocrinol (Copenh). 1992; 126: 501-504.
64. Cascella T, Palomba S, Tauchmanovà L, et al. Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2006; 91: 4395-4400.
65. Armani D, Bordin L, Donà G, et al. Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone. Steroids. 2012; 77: 655-658.
66. Friedman DI, Streeten DHP,. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology. 1998; 50: 1099-1104.
67. Streeten DHP, Dalakos TG, Souma M, et al. Studies of the pathogenesis of idiopathic oedema. Clin Sci Mol Med. 1973; 45: 347-373.
68. Seckl J, Lightman S,. Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension. J Neurol Neurosurg Psychiatry. 1988; 51: 1538-1541.
69. Seckl JR, Lightman SL,. Intracerebroventricular arginine vasopressin causes intracranial pressure to rise in conscious goats. Brain Res. 1987; 423: 279-285.
70. Sørensen PS,. Studies of vasopressin in human cerebrospinal fluid. Acta Neurol Scand. 1986; 74: 81-102.
71. Skau M, Goetze JP, Rehfeld JF, Jensen R,. Natriuretic pro-peptides in idiopathic intracranial hypertension. Reg Pept. 2010; 164: 71-77.
72. Sugarman HJ, DeMaria EJ, Felton WL, Nakatsuka M, Sismanis A,. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology. 1997; 49: 507-511.
73. Schwartz KM, Luetmer PH, Hunt CH, et al. Position-related variability of CSF opening pressure measurements. Am J Neuroradiol. 2013; 34: 904-907.
74. Abel AA, Brace JR, McKinney AM, et al. Comparison of cerebrospinal fluid opening pressure in the prone and lateral decubitus positions. J Neuroopthalmol. In Press.
75. Digre KB, Varner MW, Corbett JJ,. Pseudotumor cerebri and pregnancy. Neurology. 1984; 34: 721-729.
76. Whiteley W, Al-Shahi R, Warlow CP, Zeidler M, Lueck CJ,. CSF opening pressure: Reference interval and the effect of body mass index. Neurology. 2006; 67: 1690-1691.
77. Bono F, Lupo MR, Serra P, et al. Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology. 2002; 59: 1641-1643.
78. Ireland B, Corbett JJ, Wallace RB,. The search for causes of idiopathic intracranial hypertension: A preliminary case-control study. Arch Neurol. 1990; 47: 315-320.
79. Guiseffi V, Wall M, Siegel PZ, Rojas PB,. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): A case-control study. Neurology. 1991; 41: 239-244.
80. Radhakrishnan K, Thaker AK, Bohlaga NH, Maloo JC, Gerryo SE,. Epidemiology of idiopathic intracranial hypertension: A prospective and case-control study. J Neurol Sci. 1993; 116: 18-28.
81. Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: A case control study. Neurology. 2011; 76: 1564-1567.
82. Hannerz J, Greitz D, Ericson K,. Is there a relationship between obesity and intracranial hypertension? Int J Obes Relat Metab Disord. 1995; 19: 240-244.
83. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB,. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010; 81: 428-432.
84. Mendelson CR, Simpson ER,. Regulation of estrogen biosynthesis by human adipose cells in vitro. Mol Cell Endocrinol. 1987; 52: 169-176.
85. Misso ML, Jang C, Adams J, et al. Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause. 2005; 12: 210-215.
86. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA. 2003; 100: 14211-14216.
87. Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology. 2009; 72: 304-309.
88. Fraser JA, Bruce BB, Rucker J, et al. Risk factors for idiopathic intracranial hypertension in men: A case-control study. J Neurol Sci. 2010; 290: 86-89.
89. Thurtell MJ, Trotti LM, Bixler EO, et al. Obstructive sleep apnea in idiopathic intracranial hypertension: Comparison with matched population data. J Neurol. 2013; 260: 1748-1751.
90. Smeland S, Bjerknes T, Malaba L, et al. Tissue distribution of the receptor for plasma retinol-binding protein. Biochem J. 1995; 305: 419-424.
91. MacDonald PN, Bok D, Ong DE,. Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat and human. Proc Natl Acad Sci USA. 1990; 87: 4265-4269.
92. Morrice G Jr, Havener WH, Kapetansky F,. Vitamin a intoxication as a cause of pseudotumor cerebri. JAMA. 1960; 173: 1802-1805.
93. Selhorst JB, Waybright EA, Jennings S, Corbett JJ,. Liver lover's headache, pseudotumor cerebri and vitamin A intoxication. JAMA. 1984; 252: 3364.
94. de Veer G,. From 'a true description of three voyages by the north-east towards Cathay and China. In:, Charles T, ed. Beke. New York: Cambridge University Press; 1853. Reprinted 2009.
95. Friedman DI,. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005; 6: 29-37.
96. Millen JW, Woollam DHM,. Vitamins and the cerebrospinal fluid. In:, Wolstenholme GEW, O'Connor CMJ, A Churchill Ltd, eds. The CIBA Foundation Symposium on the Cerebrospinal Fluid. London: Novartis Foundation Symposium; 1958: 168-188.
97. Panozzo G, Babighian S, Bonora A,. Association of xerophthalmia, flecked retina, and pseudotumor cerebri caused by hypovitaminosis A. Am J Ophthalmol. 1998; 125: 708-710.
98. Calhoun MC, Hurt HD, Eaton HD, Rousseau JE Jr, Hall RC Jr,. Rates of formation an absorption of cerebrospinal fluid in bovine hypovitaminosis A. J Dairy Sci. 1967; 50: 1489-1494.
99. Hayes KC, McCombs HL, Faherty TP, et al. The fine structure of vitamin A deficiency. II Arachnoid granulations and CSF pressure. Brain. 1971; 94: 213-224.
100. Kushida A, Tamura H,. Retinoic acids induce neurosteroid biosynthesis in human glial Gl-1 cells via the induction of steroidogenic genes. J Biochem. 2009; 146: 917-923.
101. Baker ME, Funder JW, Kattoula SR,. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors. J Steroid Biochem Mol Biol. 2013; 137: 57-70.
102. Jacobson DM, Berg R, Wall M, et al. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology. 1999; 53: 1114-1118.
103. Warner JE, Bernstein PS, Yemelyanov A, et al. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol. 2002; 52: 647-650.
104. Warner JE, Larson AJ, Bhosale P, et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol. 2007; 258-262.
105. Frey SK, Vogel S,. Vitamin A metabolism and adipose tissue biology. Nutrients. 2011; 3: 27-29.
106. Braunhut SJ, Palomares M,. Modulation of endothelial cell shape and growth by retinoids. Microvasc Res. 1991; 41: 47-62.
107. Fainaru O, Adini I, Benny O, et al. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J. 2008; 22: 3728-3735.
108. Walsh FB,. Papilloedema associated with increased intracranial pressure in Addison's disease. Arch Ophthalmol. 1952; 47: 86.
109. Laurence BM, Matthews WB, Shephard RH,. Raised intracranial pressure associated with triamcinolone. Lancet. 1960; 2: 701-702.
110. Zada G, Tirosh A, Kaiser UB, Woodmansee WW,. Cushing's disease and idiopathic intracranial hypertension: Case report and review of underlying pathophysiological mechanisms. J Clin Endocrinol Metab. 2010; 95: 4850-4854.
111. Johnston I,. The pseudotumor syndrome. MD thesis, 1992;University of Dundee, UK.
112. Liu GT, Kay MD, Bienfang DC, Schatz NJ,. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol. 1994; 117: 352-357.
113. Sato O, Hara M, Asai T, Tsugane R, Kageyama N,. The effect of dexamethasone phosphate on the production rate of CSF in the spinal subarachnoid space of dogs. J Neurosurg. 1973; 39: 480-484.
114. Pollay M,. Pharmacological manipulation of cerebrospinal fluid secretion. In:, Segal MB, ed. Barriers and Fluids of the Eye and Brain. London: Macmillan Press; 1992: 49-58.
115. Johnston I, Gilday DL, Hendrick EB,. The effects of steroids and steroid withdrawal on CSF absorption. An experimental study in dogs. J Neurosurg. 1975; 42: 690-695.
116. Lindvall-Axelsson M, Owman C,. Actions of sex steroids and corticosteroids on rabbit choroid plexus as shown by changes in transport capacity and rate of cerebrospinal fluid formation. Neurol Res. 1990; 12: 181-186.
117. Gorodeski GI,. Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occluding. Endocrinology. 2007; 148: 218-231.
118. Greer M,. Benign intracranial hypertension (pseudotumor cerebri). In:, Vinken PJ, de Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam: Elsevier; 1974: 150-166.
119. Wall M, Dollar JD, Sadun AA, Kardon R,. Idiopathic intracranial hypertension. Lack of histological evidence for cerebral edema. Arch Neurol. 1995; 52: 141-145.
120. Weisberg LA,. Computed tomography in benign intracranial hypertension. Neurology. 1985; 35: 1075-1078.
121. Carreras FL, Lehmann GL, Ferri D, Tioni MF, Calamita G, Marinelli RA,. Defective hepatocyte aquaporin-8 expression and reduced canalicular membrane water permeability in estrogen-induced cholestasis. Am J Physiol Gastrointest Liver Physiol. 2007; 292: G905-G912.